FIELD: pharmaceutics.
SUBSTANCE: invention relates to chrome neon compounds with formula I possessing properties of PI3-kinase enzymes inhibitor or its pharmaceutically acceptable salts, pharmaceutical compositions based on them. In general formula I R1 represents C1-4alkyl, possibly substituted hydroxy; R2 represents C1-4alkyl; or R1 and R2 form together 4-6-member nitrogen-containing heterocyclic ring system which optionally contains 1 additional heteroatom selected from oxygen and sulphur, where sulphur ring atom is optionally oxidated with formation of S-oxide(-s), where said ring is possibly substituted with hydroxy; R3 and R5 are independently selected from H, halogen, C1-3alkoxy and cyano; R4 represents H or fluorine; n equals to 0 or 1.
EFFECT: prevention and treatment of tumours sensitive to inhibition of PI3-kinase enzymes.
15 cl, 4 dwg, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
NOVEL TETRAZOLONE DERIVATIVES | 2014 |
|
RU2664644C2 |
PYRIMIDYL CYCLOPENTANES AS AKT-PROTEIN KINASE INHIBITORS | 2008 |
|
RU2486178C2 |
AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS INHIBITOR OF TYROSINE KINASE RECEPTOR OF NEUROTROPHIC FACTOR | 2017 |
|
RU2764523C2 |
PYRAZINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2809631C2 |
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
OXAZINMONOACYLGLYCERIN LIPASE (MAGL) INHIBITORS | 2019 |
|
RU2794334C2 |
SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, SYNTHESIS AND APPLICATION METHOD | 2010 |
|
RU2452735C1 |
MKK4 PROTEIN KINASE INHIBITORS FOR STIMULATION OF LIVER REGENERATION OR REDUCTION OR PREVENTION OF HEPATOCYTE DEATH | 2019 |
|
RU2788000C2 |
TRIAZOLPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATMENT OF CANCER | 2019 |
|
RU2793249C2 |
DERIVATIVES OF INDOLIN-2-SHE AS INHIBITORS OF PROTEINKINAS | 2013 |
|
RU2627706C2 |
Authors
Dates
2016-09-20—Published
2012-04-12—Filed